Stroke management pathway during COVID-19 pandemic scientific statement by the Saudi Stroke Society

Neurosciences (Riyadh). 2020 Jul;25(3):226-229. doi: 10.17712/nsj.2020.3.20200079.
No abstract available

MeSH terms

  • Anticonvulsants / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Humans
  • Pandemics
  • Patient Care / methods*
  • Pneumonia, Viral / complications*
  • SARS-CoV-2
  • Saudi Arabia
  • Societies, Medical*
  • Stroke / complications*
  • Stroke / drug therapy*

Substances

  • Anticonvulsants